Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T cell progenitors through its ProTcell platform to provide targeted treatments like off-the-shelf CAR T. The Company is headquartered in Paris, France, at Paris Biotech Santé.
View Top Employees from Smart ImmuneWebsite | http://www.smart-immune.com |
Employees | 38 (26 on RocketReach) |
Founded | 2017 |
Address | Paris Biotech santé - Pole innovation 29, Rue du Faubourg Saint-Jacques, Paris, Île-de-France 75014, FR |
Industry | Biotechnology Research, Biotechnology, Drug Discovery |
Looking for a particular Smart Immune employee's phone or email?
Olivier NEGRE is the Chief Scientific Officer of Smart Immune.
26 people are employed at Smart Immune.
Smart Immune is based in Paris, Île-de-France.